Cargando…
Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor ACE2 and TMPRSS2 in Inflammatory Bowel Disease
Autores principales: | Nowak, Jan Krzysztof, Lindstrøm, Jonas Christoffer, Kalla, Rahul, Ricanek, Petr, Halfvarson, Jonas, Satsangi, Jack |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217073/ https://www.ncbi.nlm.nih.gov/pubmed/32413354 http://dx.doi.org/10.1053/j.gastro.2020.05.030 |
Ejemplares similares
-
Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2
por: Nowak, Jan K, et al.
Publicado: (2022) -
Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character Cohort
por: Vatn, Simen Svendsen, et al.
Publicado: (2022) -
Analysis of Systemic Epigenetic Alterations in Inflammatory Bowel Disease: Defining Geographical, Genetic and Immune-Inflammatory influences on the Circulating Methylome
por: Kalla, Rahul, et al.
Publicado: (2022) -
Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease – associations with disease phenotype, treatment, and outcome
por: Olbjørn, Christine, et al.
Publicado: (2019) -
Precision medicine in inflammatory bowel disease: concept, progress and challenges
por: Borg-Bartolo, Simon P., et al.
Publicado: (2020)